🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluate the safety of UB-421 in combination with standard antir...
Status
Completed
Location
Kaohsiung Medical University Chung-Ho Memorial Hospital
Start Date
2018-12-12
Trial ID
NCT03743376
Treatments Being Tested
UB-421 subcutaneous formulation (UB-421 SC) is developed to provide HIV inf...
Status
Unknown
Location
Multiple Locations
Start Date
2023-12-31
Trial ID
NCT04620291
Treatments Being Tested
This is a Phase 2, multi-center study, designed to evaluate the efficacy, s...
Status
Unknown
Location
Multiple Locations
Start Date
2023-12
Trial ID
NCT03164447
Treatments Being Tested
This is a Phase II, randomized, open-label, multi-center, active-controlled...
Status
Unknown
Location
Multiple Locations
Start Date
2023-12-01
Trial ID
NCT04404049
Treatments Being Tested
Background: People with HIV usually take a combination of 2 or more anti-H...
Status
Withdrawn
Location
National Institutes of Health Clinical Center
Start Date
2025-07-10
Trial ID
NCT05582694
Treatments Being Tested
The purpose of this Phase I study is to determine whether the antibody (UB-...
Status
Completed
Location
Taipei Veterans General Hospital (TVGH)
Start Date
2010-05
Trial ID
NCT01140126
Treatments Being Tested
The purpose of this Phase IIa study is to determine whether the antibody (U...
Status
Completed
Location
Taipei Veterans General Hospital (TVGH)
Start Date
2012-09
Trial ID
NCT01668043
Treatments Being Tested
This study assess the safety, tolerability, and efficacy in reducing viral ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-04
Trial ID
NCT04041362
Treatments Being Tested